pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Cell Therapy · news · pharmadog
← back to Cell Therapy
News · Cell Therapy
122
stories
Jul 15, 26
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
biopharma dive
Jul 15, 26
Why Axiom hopes it’s ‘solved 2 major potholes’ that have hurt other stem cell biotechs
fiercebiotech
Jul 10, 26
The data that led Cellular Intelligence to pick up Novo's Parkinson's stem cell therapy
endpoints
Jul 2, 26
Vertex's sickle cell therapy approved for kids; United Therapeutics buys startup
endpoints
Jul 2, 26
STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong
stat
Jul 2, 26
STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
stat
Jul 1, 26
FDA approves Orca Bio’s cell therapy to improve transplant outcomes
endpoints
Jul 1, 26
BridgeBio gets funding for drug launch; United buys into cell therapy
biopharma dive
Jul 1, 26
STAT+: Synthetic biology researchers think they’ve made a cell. Is it alive?
stat
Jul 1, 26
STAT+: More signs that GLP-1s may help with peripheral artery disease
stat
Jul 1, 26
STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients
stat
Jun 30, 26
Top FDA gene and cell therapy regulator to step down
biopharma dive
Jun 30, 26
STAT+: FDA digital leader hints at coming AI policy updates
stat
Jun 16, 26
B cell therapy maker Be Bio stops hemophilia trial
endpoints
Jun 16, 26
Neumora depression drug fails; EnGene to cut 50% of staff
biopharma dive
Jun 10, 26
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine
biopharma dive
Jun 3, 26
Legend surges on early data for ‘in vivo’ lymphoma cell therapy
biopharma dive
Jun 2, 26
Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
biopharma dive
May 29, 26
Allogene CEO to step down; Agios drug fails key test
biopharma dive
May 15, 26
#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live
endpoints
May 14, 26
AVB-001 Encapsulated IL-2 Cell Therapy Shows Safety and Immune Activity in Platinum-Resistant HGSOC
onclive
May 14, 26
#ASGCT26 dispatch: In vivo CAR-T is everywhere
endpoints
May 14, 26
Create Medicines raises $122M to bolster in vivo CAR-T therapies
biopharma dive
May 14, 26
STAT+: BeOne wins FDA approval in lymphoma race
stat
May 13, 26
FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML
onclive
May 13, 26
FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphoma
onclive
May 13, 26
Tirabrutinib and CAR T-Cell Therapy Represent Potential Paradigm Shifts in R/R PCNSL
onclive
May 13, 26
Consensus Recommendations Address Key Controversies in Lymphoma Management
onclive
May 13, 26
Abeona pivots to T cells; AstraZeneca's rare disease drug passes Phase 3
endpoints
May 13, 26
Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B
biopharma dive
← prev
page 3 of 5
next →
